Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135), Burbank
City of Hope Comprehensive Cancer Center ( Site 0191), Duarte
Bass Medical Group ( Site 0123), Walnut Creek

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06890884

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Providence Medical Foundation-Oncology ( Site 0168), Fullerton
MemorialCare Health System - Long Beach Medical Center ( Site 9559), Long Beach
Cancer Blood and Specialty Clinic ( Site 0109), Los Alamitos
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06717347

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

City of Hope, Duarte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

City of Hope, Duarte
University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Children's Hospital Los Angeles ( Site 1006), Los Angeles

Nagre-recruitPhase 1/2

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

City of Hope Medical Center, Duarte
University of California San Diego Medical Center, Moores Cancer Center, La Jolla

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07195916

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Community Cancer Institute (CCI), Clovis
Providence Medical Foundation, Fullerton
Los Angeles Cancer Network, Glendale
at 4 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06806033

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

City of Hope Comprehensive Cancer Center, Duarte
University of California Davis Comprehensive Cancer Center, Sacramento

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT05272384

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Alta Bates Summit Medical Center, Berkeley
City of Hope, Duarte
Cedars-Sinai Medical Center, Los Angeles
at 4 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06500273

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

City of Hope Medical Center, Duarte

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07365306

A Study of ARC-02 in B-cell NHL

Start Cala, Los Angeles

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

University of California-Irvine Medical Center, Irvine
Cedars-Sinai Medical Center, Los Angeles
University of California, Los Angeles (UCLA) Medical Center, Los Angeles
at 1 pa

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Cedars-Sinai Medical Center, Los Angeles

Nagre-recruitPhase 1

Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT05887167

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

City of Hope, Duarte
Valkyrie Clinical Trials, Los Angeles

Nagre-recruitPhase 1/2

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Stanford University, Stanford

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06116110

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Cedars-Sinai Medical Center, Los Angeles
University of California, Los Angeles (UCLA), Los Angeles
University of California, Irvine, Orange

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

A Long-term Extension Study of PCI-32765 (Ibrutinib)

St. Joseph Hospital Center for Cancer Prevention and Treatment, Orange

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT01804686

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

START Los Angele, Los Angeles

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07424833

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

University of California Davis Comprehensive Cancer Center, Sacramento

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT05052528

DALY II USA/ MB-CART2019.1 for DLBCL

UC San Diego Health, La Jolla
Stanford University, Stanford

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

City of Hope Medical Center, Duarte

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05672251

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

City of Hope Comprehensive Cancer Center, Duarte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05077527

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

City of Hope Comprehensive Cancer Center, Duarte
University of California Davis Comprehensive Cancer Center, Sacramento

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT06015880

Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

University of California Davis Comprehensive Cancer Center, Sacramento

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT06854159

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

City of Hope, Duarte
University of California, San Francisco, San Francisco

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

University of California Davis Comprehensive Cancer Center, Sacramento

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT06905509

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

University of California, San Francisco, San Francisco

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT04545762

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

City of Hope Medical Center, Duarte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT06859008

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

City of Hope, Duarte
Los Angeles Cancer Network, Los Angeles
UCLA Medical Center of Hematology/Oncology, Los Angeles
at 1 pa

Nagre-recruitPhase 1/2

Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

City of Hope, Duarte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
University of California Davis Comprehensive Cancer Center, Sacramento

Nagre-recruitPhase 1/2

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT05256641

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

City of Hope Medical Center, Duarte

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT07042438

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

City of Hope Medical Center, Duarte

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 23, 2026 · NCT05432635

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

City of Hope Medical Center, Duarte

Nagre-recruitMaagang Phase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 4, 2026 · NCT05800405

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

UC Irvine Health Cancer Center-Newport, Costa Mesa
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UCI Health Laguna Hills, Laguna Hills
at 2 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT05633615

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Tower Cancer Research Foundation, Beverly Hills
City of Hope Comprehensive Cancer Center, Duarte
City of Hope Seacliff, Huntington Beach
at 7 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT05890352

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.